Tag: in vitro dissolution

IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Bioequivalence Testing

Posted by: Alan Burity Vitulo in: Industry Insights

22 Jan | 11:20 AM | 9

IVIVC lets pharmaceutical companies predict how a drug behaves in the body using lab-based dissolution tests, replacing costly and time-consuming human trials. When done right, it saves millions and speeds up generic drug approval.

Bioequivalence of Combination Products: Special Testing Challenges

Bioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.

Social Media Education: How Digital Platforms Are Transforming Patient Education

Social media is transforming how patients learn about generic drugs. From TikTok explainers to Instagram Reels, digital platforms are cutting through confusion and building trust-no brochures needed.

Tramadol and Seizure Risk: What Patients with Seizure Disorders Need to Know

Tramadol can lower the seizure threshold even at normal doses, making it dangerous for people with seizure disorders. Learn why it's contraindicated, who's at risk, and what safer alternatives exist.

Seized Counterfeit Medications: Real Cases and What We've Learned

Counterfeit medications are a growing global threat, with millions of fake pills and injections seized each year. Real cases from 2025 reveal how dangerous these fakes are-and what we must do to stop them.

Fake Generic Drugs: How Counterfeits Enter the Supply Chain

Fake generic drugs are a growing global threat, infiltrating supply chains through loopholes in regulation, online sales, and grey market distribution. Learn how they’re made, how they get into pharmacies, and what you can do to protect yourself.

Tag: in vitro dissolution

IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Bioequivalence Testing

recent posts

categories

archives

tags